Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Cancer research institute
Oct 13, 2023, 12:32 |
Blog
Silencing the voice of democracy in Nagorno-Karabakh: the unfolding forced displacement crisis
by Stella Arakelyan, MD, MPH, MSc, PhD 1,2 , Jemma Arakelyan, MD, PhDc 2,3 ,…
Oct 12, 2023, 20:57 |
Insight
Erika Hamilton: Excited to see further updates from monarchE at ESMO23.
Erika Hamilton, made the following post on LinkedIn: "Excited to see further updates from monarchE…
Oct 12, 2023, 02:36 |
Blog
Paolo Tarantino: Truly grateful for the kind invitation and incredibly warm welcome by the Argentinian and Patagonian associations of clinical oncology.
Quoting Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, on X/Twitter: "Truly…
Oct 10, 2023, 16:10 |
Blog
,
Opinion
Roupen Odabashian: Here are some factors contributing to the nursing shortage, drawn from personal experiences...
Quoting Roupen Odabashian, Haematology-Oncology Fellow at Karmanos Cancer Institute, on LinkedIn: ''During my residency, a pattern…
Oct 10, 2023, 15:47 |
Opinion
Jill Feldman: The true art of oncology is understanding that the right approach/treatment MUST align with the soul, preferences and dreams of the patient (and fam) in front of you.
Oct 9, 2023, 18:18 |
Blog
Vivek Subbiah: Mark your calendars if you are attending the NCI AACR EORTC 2023- The triple meeting in Boston, Oct 11-15.
Vivek Subbiah shared on LinkedIn: “Mark your calendars if you are attending the NCI AACR…
Oct 7, 2023, 17:20 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 7
We continue OncoDaily’s '100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social…
Oct 6, 2023, 17:14 |
Blog
Roupen Odabashian: This is an interesting article on how Ph.D. holders are leaving academia.
Quoting Roupen Odabashian, Haematology-Oncology Fellow at Karmanos Cancer Institute, on LinkedIn: “This is an interesting article…
Oct 6, 2023, 15:32 |
Blog
Paolo Tarantino: Bright days ahead for ESMO journals!
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared on X/Twitter: “Congrats to the…
Oct 5, 2023, 17:42 |
Insight
Vivek Subbiah: Still remember the 1st ever patient enrolled on the trial in the peak of the pandemic.
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at The Sarah Cannon Research Institute, on…
272
273
274
275
276
All:
2812
Posts:
2731 - 2740
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube